CDCA3 and pachyonychia congenita: In conclusion, the present study illustrates that circTNPO3 might promote the occurrence, progression and chemotherapy resistance of PC by miR-188-5p/CDCA3/TRAF2/NF-κB axis in vivo and in vitro (Figure 9).